Table:
begin	end	state
1	25	non-cytoplasmic
26	48	transmembrane
49	57	cytoplasmic
58	81	transmembrane
82	83	cytoplasmic
84	88	non-cytoplasmic
89	132	transmembrane
133	151	non-cytoplasmic
152	171	transmembrane
172	178	cytoplasmic
179	201	transmembrane
202	212	non-cytoplasmic
213	232	transmembrane
233	251	cytoplasmic
252	275	transmembrane
276	329	non-cytoplasmic
330	352	transmembrane
353	380	cytoplasmic
381	400	transmembrane
401	405	non-cytoplasmic
406	426	transmembrane
427	437	cytoplasmic
438	457	transmembrane
458	463	non-cytoplasmic
464	481	transmembrane
482	512	cytoplasmic

Input:
>Ga0059261_1053
MIFGRVKPLDAILATAEKKSLHRSLGAFQLTMLGIGAVIGTGIFVLTAEAAQKAGPGMML
SFVIAGVVCAVAALCYAEMAAMVPVSGSAYTYSYAVMGELIAWMVGWALILEYAVAAGAV
SVGWSGYVVGLIENAFALDIPDALVRGPYDGGIINLPAMLIAGLVTWLLVIGTKESAFVN
SVLVLVKVSALSLFIILAIPVMNMQNFEPFSPLGFAGVSAAAASIFFAYVGFDAVSTAAE
ETKNPQRNMPIGLIGSLAICTIFYLLVAAGVIGSVGAQPILGPDGAALPPGSTELTKACV
ETAAATGKEAVVCSKEALAWTLREIGWPQIGNLIGLAAGLALPSVILMMMFGQTRIFFVM
SRDGLLPAVFSKVHPKFHTPHVITILTGVFVALFAAFFPVGKLADISNSGTLFAFAAVSI
AVLVLRRTDPDRKRPFRTPLIIITAPIAILGCAYLFYSLGHDTKMMFVGWAALGLLVYFG
YSRRKSHVGRGIVETPEHEAYQELDPPVPGTH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server